CSF2 and autoimmune pulmonary alveolar proteinosis: The administration of GM-CSF has, however, been reported to improve pulmonary function in patients with autoimmune pulmonary alveolar proteinosis, although there is no evidence for its value in managing infections associated with anti-GM-CSF autoantibodies [3].